Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares. - Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, May 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Safety Needles Industry" - https://www.reportlinker.com/p06032819/?utm_source=GNW - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass Research Platform - Complimentary updates for one year - Global Safety Needles Market to Reach US$3.6 Billion by the Year 2026 - Safety needles refer to injection needles that have been specifically designed to ensure safety of healthcare workers, support staff and patients from needlestick injuries or even infections that they might get exposed to during the course of needle use. They are widely used for administering drugs and collecting blood samples (even other body fluids), and provide protection against bloodborne pathogens and detrimental drug exposure. The global safety needles market is expected to continue to grow at a healthy rate, led mainly by implementation of rigorous laws promoting safe injection practices, amid the escalating cases of needle stick injuries worldwide. Safety needles help decrease the cost burden, minimize the occurrence of iatrogenic infection, and prevent the risk of transmission of bloodborne viruses while protecting patients from needlestick injuries (as evident when administering Covid-19 vaccines), all of which also contribute to market growth. Other factor driving demand for safety needles include the expanding patient population with chronic diseases, growing awareness of the risk posed by filled syringes, and increased global usage of prefilled syringes. Further, innovation is driving medical device manufacturers to develop and launch needle-based safety devices (both passive and active safety systems), which can be attached manually to a conventional syringe or to commercially available pre-filled syringe. Advancements in technology and quality upgrades are expected to enable companies manufacture safety needles with the highest of safety standards. - Amid the COVID-19 crisis, the global market for Safety Needles estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$3.6 Billion by 2026, growing at a CAGR of 8.2% over the analysis period. Active, one of the segments analyzed in the report, is projected to grow at a 9.5% CAGR to reach US$2.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Passive segment is readjusted to a revised 5.2% CAGR for the next 7-year period. This segment currently accounts for a 21.3% share of the global Safety Needles market. Among active and passive safety needles, active safety needles represent the most selling safety needles in the global market. The increase in global needlestick injury numbers, and low-cost of active needles have led to widespread adoption of active safety needles in almost all countries. The U.S. Market is Estimated at $871.8 Million in 2022, While China is Forecast to Reach $286.3 Million by 2026 - The Safety Needles market in the U.S. is estimated at US$871.8 Million in the year 2022. The country currently accounts for a 33.87% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$286.3 Million in the year 2026 trailing a CAGR of 10.5% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR while Rest of European market (as defined in the study) will reach US$277.3 Million by the end of the analysis period. North America represents the largest regional market for safety needles, where demand is driven by increasing cases of needlestick injury, escalating incidence and prevalence of chronic disorders, and an expanding geriatric population who stand greater risk of developing age-related disorders. Additional growth drivers include easy product availability, higher adoption rates, higher per capita healthcare spending and presence of major manufacturers in the region. Meanwhile, Asia-Pacific is witnessing demand grow for safety needles owing to increase in number of people suffering from chronic diseases such as diabetes, a huge patient base suffering from infectious diseases, greater availability and adoption of safety needle systems, and rise in awareness of the detrimental effect of needlestick injuries. - Passive Safety Needles Segment to Reach $642.7 Million by 2026 - Passive needles are automatic, eliminating requirement for manual intervention for activating its safety feature, and hence expensive. The adoption of passive needles is taking place at much faster pace than that of active needles, as users are benefiting from the additional features such as absence of extra assembly parts, which eases disposal for users and lesser packaging space, which benefits manufacturers. In the global Passive Safety Needles segment, USA, Canada, Japan, China and Europe will drive the 5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$381 Million will reach a projected size of US$534 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$54.1 Million by the year 2026, while Latin America will expand at a 6.3% CAGR through the analysis period. Select Competitors (Total 101 Featured) Argon Medical Devices, Inc. B. Braun Melsungen AG Becton, Dickinson and Company Boston Scientific Corporation Cardinal Health, Inc. Johnson & Johnson (Ethicon Inc.) Medtronic plc Nipro Corporation Novo Nordisk A/S Retractable Technologies, Inc. Smiths Group Plc. Terumo Corporation Vygon SA Read the full report: https://www.reportlinker.com/p06032819/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Impact of Covid-19 and a Looming Global Recession The Never-Ending ?Race? Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond? Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic EXHIBIT 1: Time is of Essence! What We Know So Far - ?Vaccine Efficiency Against New Strains? With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking. But How Practical Is It to Implement Them? EXHIBIT 2: With Vaccinated Population Showing Signs of Declining Clinical Protection, Booster Doses Are Emerging Into a Necessity to Restore Vaccine Effectiveness: Number of Booster Doses Administered Per 100 People by Country as of December 2021 How Healthcare Has Been Impacted & Beyond COVID-19 What?s In Store for Healthcare? EXHIBIT 3: Missed Cancer Diagnosis in U.S. as of June 2020 EXHIBIT 4: % Reduction in OR Volumes in the US: Mar 2020-July 2020 EXHIBIT 5: Cumulative Surgery Cancellations Worldwide (In Million) EXHIBIT 6: With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP COVID-19 and Postponement of Elective Surgeries Impact of COVID-19 on Safety Needles Market Competition EXHIBIT 7: Safety Needles - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2022 (E) Needles: A Prelude Types of Needles A Prelude to Safety Needles Global Market Overview Global Safety Needles Market Set to Grow Active Safety Needles Account for a Major Share Hospitals and Ambulatory Surgery Centers US and Europe Dominate the Market, Asia-Pacific to Witness Fastest Growth Recent Market Activity WORLD BRANDS 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Legislations Curb Needle Stick Injuries Drive Demand for Safety Syringes and Needles Rising Incidence of Hospital Acquired Infections Propels Demand for Safety Needles EXHIBIT 8: Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost from Leading Five Infections Rise in Number of Surgeries Buoys Growth EXHIBIT 9: Global Volume of Surgical Procedures (in Million) by Category: 2019 EXHIBIT 10: Growth in the Number of Surgeries in the US (2010- 2020) and 2001-2010 (in %) EXHIBIT 11: Number of Surgical Procedures (per 100,000 People) in Select Countries Innovation Helps in Improving Trust for Safety Pen Needles Growing Use of Self-Injection Devices to Boost Growth Needle-Free Innovations to Make Hypodermic Needles Go into Oblivion Needleless Systems Pose Threat to Traditional Syringes Increased Demand for Use of Safety Needles & Insulin Pens in Hospital Settings MACRO GROWTH DRIVERS Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities EXHIBIT 12: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, and 2023 Aging Population and Growing Number of Surgical Procedures Spur Demand EXHIBIT 13: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 EXHIBIT 14: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 Growing Prevalence of Chronic Diseases Drive the Demand for Safety Needles EXHIBIT 15: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 EXHIBIT 16: Global Number of New Cancer Cases and Cancer- related Deaths by Cancer Site for 2018 EXHIBIT 17: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others EXHIBIT 18: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045 EXHIBIT 19: World Diabetes Prevalence (2000-2019) 4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Safety Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Safety Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Safety Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 Table 4: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 7: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 13: World Recent Past, Current & Future Analysis for Hospitals & Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Hospitals & Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Hospitals & Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 16: World Recent Past, Current & Future Analysis for Diabetic Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Diabetic Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Diabetic Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 19: World Recent Past, Current & Future Analysis for Family Practice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Family Practice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Family Practice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 22: World Recent Past, Current & Future Analysis for Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 III. MARKET ANALYSIS UNITED STATES Safety Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) Market Analytics Table 28: USA Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 29: USA Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: USA 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 31: USA Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 32: USA Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: USA 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 CANADA Table 34: Canada Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: Canada Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: Canada 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 37: Canada Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: Canada Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: Canada 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 JAPAN Table 40: Japan Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: Japan Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: Japan 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 43: Japan Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Japan Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Japan 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 CHINA Table 46: China Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: China Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: China 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 49: China Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: China Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: China 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 EUROPE Safety Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) Market Analytics Table 52: Europe Recent Past, Current & Future Analysis for Safety Needles by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 53: Europe Historic Review for Safety Needles by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Europe 15-Year Perspective for Safety Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 Table 55: Europe Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Europe Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Europe 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 58: Europe Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Europe Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Europe 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 FRANCE Table 61: France Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: France Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: France 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 64: France Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: France Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: France 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 GERMANY Table 67: Germany Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Germany Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Germany 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 70: Germany Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: Germany Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Germany 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 ITALY Table 73: Italy Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Italy Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Italy 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 76: Italy Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Italy Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Italy 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 UNITED KINGDOM Table 79: UK Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: UK Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: UK 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 82: UK Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: UK Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: UK 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 SPAIN Table 85: Spain Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Spain Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Spain 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 88: Spain Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Spain Historic Review for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Spain 15-Year Perspective for Safety Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses for the Years 2012, 2021 & 2027 RUSSIA Table 91: Russia Recent Past, Current & Future Analysis for Safety Needles by Product Type - Active, Passive and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Russia Historic Review for Safety Needles by Product Type - Active, Passive and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Russia 15-Year Perspective for Safety Needles by Product Type - Percentage Breakdown of Value Sales for Active, Passive and Other Product Types for the Years 2012, 2021 & 2027 Table 94: Russia Recent Past, Current & Future Analysis for Safety Needles by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practice, Psychiatry and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Please contact our Customer Support Center to get the complete Table of Contents Read the full report: https://www.reportlinker.com/p06032819/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

As you might know, Health Catalyst, Inc. ( NASDAQ:HCAT ) just kicked off its latest quarterly results with some very...

GrainCorp Limited ( ASX:GNC ) defied analyst predictions to release its half-year results, which were ahead of market...

Block, Inc. (NYSE:SQ) is on the receiving end of market turbulence as the stock has declined some 12% from the day on the earnings announcement. We will review how the company performed, and what do analysts expect in the future.

Last week Cloudflare ( NYSE: NET ) released good first-quarter results but indicated that revenue growth is likely to slow later in the year. The results led to an immediate 16% drop in the share price, although it has held up reasonably well since then when compared to the rest of the sector. As growth slows, the market’s focus is likely to shift to Cloudflare’s path to positive earnings.

Bitcoin gets the attention. But this physical asset could boom next.

Chinese workers are "burning the 3 a.m. oil" and don't want to leave their factories, Elon Musk told the FT, "whereas in America, people are trying to avoid going to work at all."

Mark Cuban, billionaire entrepreneur and owner of the NBA’s Dallas Mavericks, thinks that cryptocurrency is on the same downward trend that tech and internet companies hit in the early 2000s. Bitcoin hit a 10-month low on Monday, and sales of non-fungible tokens, aka NFTs, plummeted between January and March 2022. Cuban addressed the slump in a viral Twitter (TWTR) thread on Monday.

In total, Bankman-Fried acquired 56,273,469 shares, according to an SEC filing Thursday. The company Bankman-Fried is showing such an interest in is Robinhood . The online brokerage firm first drew widespread attention in early 2021 as a vehicle used by novice traders to help bid up the price of so-called meme stocks.

XRP breaks through key resistance levels this morning as investors prepare for news updates on Ripple’s reply to the SEC’s latest brief on the Hinman docs.

The stock market’s volatility may last longer than investors have come to expect—but you can still prosper with discipline, patience and courage.

The action has been so poor recently that there is little confidence that a bounce can gain traction, and that causes any upward movement to be quickly sold. Myovant Sciences is a biotechnology name that has had very positive news and has a clear support level now at around $8.

The S&P 500, which is dominated by mega-cap stocks, has dropped 17% this year. But there may be opportunities.

RBC Capital analyst Walter Spracklin lowered the price target for CCL Industries Inc (TSX: CCL.B) (OTC: CCDBF) to C$74 from C$80. The analyst maintained the Outperform rating on the shares. Spracklin states that 1Q22 results came in above expectations and (in contrast with last quarter) there was no cautionary language around near term trends. The company indicated that further cost pas through initiatives would complement those already successfully implemented to date, which we believe should b

Crypto has been dominated by younger and middle-aged adults. The digital asset industry wants that to change.

Peloton stock was a top performer in the coronavirus stock market rally. But it's spun out over the past year.

Since the beginning of the year, markets have been more turbulent than normal with the S&P 500 being down 15.65%. But one sector can offer high yields and diversification in falling markets: non-traded real estate investment trusts (REITs). Like publicly traded REITs, non-traded REITs invest in real estate companies in various niches like office space, shopping malls and healthcare facilities. Some might also invest in mortgages and mortgage-backed securities. Many non-traded REITs, like RealtyM

The West has imposed an unprecedented package of sanctions on Russia, its top companies and its business and political elite in response to Moscow's invasion of Ukraine. The measures have triggered an exodus of foreign firms, raised the prospect of Russia defaulting on its sovereign debt, and look set to trigger a deep economic contraction. The Group of Seven major Western powers have banned transactions with Russia's central bank and frozen its assets held in their jurisdictions – around $300 billion, according to Russian Finance Minister Anton Siluanov.

WASHINGTON (Reuters) -The U.S. Senate on Thursday confirmed Jerome Powell to a second four-year term as head of the Federal Reserve, paving the way for the former investment banker to continue leading the central bank as it confronts the highest inflation in 40 years. Powell, who was renominated by U.S. President Joe Biden, drew bipartisan backing in the divided Senate, with a final tally of 80 senators in favor of his confirmation and only 19 opposed. Most of the nays were Republicans, though a few Democrats, including Robert Menendez and Elizabeth Warren, joined them.

Rising mortgage rates mean the average American family pays 34% of monthly income to afford the typical family home, Black Knight says. It's not all bad news, though.

Global shares sank to their lowest point in 18-months on Thursday while the dollar hit a 20-year-high, as investors feared that inflation pushing up interest rates will bring the global economy to a standstill. The Dow Jones Industrial Average fell 160.04 points, or 0.5%, the S&P 500 lost 6.9 points, or 0.18%, and the Nasdaq Composite added 65.04 points, or 0.57%. "We have had big moves," UBS's UK Chief Investment Officer Caroline Simmons, said, also referring to bond markets and economic expectations.